BioAtla, Inc. Collaboration Agreements
3 Contracts & Agreements
- Master Clinical Trial Collaboration Agreement, dated January 5, 2022, by and between BioAtla, Inc. and Bristol-Myers Squibb Company (Filed With SEC on November 4, 2022)
- Amendment No. 3 to Global Co-Development and Collaboration Agreement between BioAtla, Inc. and BeiGene, Ltd (Filed With SEC on February 28, 2022)
- Global Co-Development and Collaboration Agreement with BeiGene, Ltd. and BeiGene Switzerland GmbH, dated April 8, 2019, as amended by First Amendment, dated December 24, 2019 and... (Filed With SEC on November 13, 2020)
